[Chronic obstructive pulmonary disease phenotypes and the related characteristics of treatment response].
Ming-ming
MM
Pan
Tie-ying
TY
Sun
Chen
C
Wang
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D015415:Biomarkers / Q000097:blood; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006801:Humans; D010641:Phenotype; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D011656:Pulmonary Emphysema / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D012129:Respiratory Function Tests; D012307:Risk Factors; D012720:Severity of Illness Index; D018746:Systemic Inflammatory Response Syndrome / Q000150:complications
D018927:Anti-Asthmatic Agents; D015415:Biomarkers; D001993:Bronchodilator Agents